Cder advancing rare disease cures program

Ended Awarded Last action

Contract number
75F40122F19014
Awardee
Awarding agency
Obligated
$3,897,869

Award facts

Contract value 94% obligated
  • $3,897,868.82 Current, with exercised options
  • $4,127,430.52 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Other Administrative Action P00007 $285,638
Other Administrative Action P00006 $0
Other Administrative Action P00005 · Eagle hill consulting the business process improvement/strategic planning (BPI) tier 2 blanket purchase agreement (BPA) (contract no. 75F40122A00009) order… $865,488
Other Administrative Action P00004 · Update funding $0
Exercise an Option P00003 $1,490,143
Exercise an Option P00002 $228,013
Additional Work (new agreement, FAR part 6 applies) P00001 · Incorporate option year i $0
Original award $1,028,586

About this award

This federal contract award is for a Blanket Purchase Agreement (BPA) call order under the Business Process Improvement/Strategic Planning (BPI) Tier 2 BPA with the Food and Drug Administration (FDA). The prime contractor is Eagle Hill Consulting, LLC, a woman-owned management consulting firm based in Arlington, Virginia. The contract, valued at $4,127,430.52, is to provide project management support for the FDA's Center for Drug Evaluation and Research (CDER) Advancing Rare Disease Cures Program. This is not a set-aside contract. The contract has an ultimate completion date of July 17, 2025 and was awarded on June 23, 2022. Eagle Hill Consulting holds several significant federal contract Indefinite Delivery Vehicles (IDVs), including a $149 million BPA with the FDA for strategic planning and organizational change management, and a $100 million BPA for business process improvement and strategic planning.

Quick answers

Who was awarded contract 75F40122F19014?

75F40122F19014 was awarded to Eagle Hill Consulting, LLC by Food and Drug Administration (Department of Health and Human Services) on June 23, 2022.

How much is contract 75F40122F19014 worth?

The government has obligated $3,897,869 on 75F40122F19014. Its potential value, with all options, is $4,127,431.

Is contract 75F40122F19014 an order under another contract?

Yes. 75F40122F19014 is a BPA call under GS02F010GA-75F40122A00009, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40122F19014 competed?

The extent of competition for 75F40122F19014 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award